Mineralys Therapeutics, Inc.: Mineralys Therapeutics Announces Pricing of $175.0 Million ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic ...